Evicenter
MarkdownMedical informationP&T meetings
Lysergide (DT120)

Generalized anxiety disorder

Also known as MM120
Launch
Not announced
Last updated
199 sources

Product information and disease descriptionProduct description

Phase of product development

22 evidence topics · 23 sources

Launch

No evidence found.

Investigational status and current development phase
Controlled substance scheduling: rescheduling by the DEA and states required after approval
Executive Order 14401 of April 2026: priority vouchers and timely rescheduling of psychedelic drugs